InvestorsHub Logo

JWC3

04/18/21 11:05 AM

#307474 RE: Jonjones325 #307471

My guess too! Must be PA with rollout for AD, PD, PDD, RTT!

bennyboy1

04/18/21 11:08 AM

#307475 RE: Jonjones325 #307471

JJ: We do not know all the details, but I truly believe we are on to SOMETHING BIG!!! We will change the landscape, and ANAVEX 2-73 will be a BLOCKBUSTER!!!

Jonjones325

04/18/21 11:54 AM

#307477 RE: Jonjones325 #307471

He’s been working there for 4 months beginning January 2021, soon after we released PDD results.

Hammond Care has been good to us. Yes it’s a business relationship but over the years it probably has developed into more.

So why take one of their top employees? Seems kind of messed up. You couldn’t find someone else?

Unless they are cooperating on something. Speculation Sunday!!

tredenwater2

04/18/21 2:15 PM

#307486 RE: Jonjones325 #307471

Perhaps its due to the fact that over half maybe as much as 2/3 of patients on OLE are in Australia. I wouldnt put it past DrM to run a Ph 2/3 PD/PDD in AU. Why not? Shake it up is “down under”, they are organised, and the tax credit! Perhaps they follow the Alzheimer’s model and start off with enrolling half the Ph 2/3 Parkinsons and then “globetrot” from there.

Speaking of globe trotting, if the second Parkinsons trial is a PDD, can they use the same enrolment sites that they currently have set up for the Alzheimer’s trials for recruitment? Now that would be an expedited bonus!

Just some random thoughts.

Cheers